Your partner for method development: Da Vinci LS

Chromatography

Your partner for method development: Da Vinci LS

02 Jun, 2026

Have you ever needed to develop or alter chromatography methods but lacked the resources to do so? To compare different sample introduction techniques and determine which truly performs best for specific analytes? Or to investigate a persistent malodour issue and establish a robust link between sensory perception and the underlying chemistry?

These are not uncommon challenges. They are questions many laboratories want to explore but often cannot because of limited time, personnel or instrumentation. Da Vinci Laboratory Solutions UK & Ireland’s consultancy offering is designed to bridge exactly that gap by working collaboratively with laboratories to advance their scientific research.

The company’s fully equipped laboratory and team of experienced analytical chemists are available to assist. From feasibility and qualification studies through planning, development and reporting, the team remains in close dialogue with clients, refining direction where needed and ensuring the work remains aligned with project goals.

For organisations considering a scientific challenge that would benefit from additional expertise or alternative technologies, Da Vinci LS can support the definition and execution of an appropriate study. To find out whether this approach is suitable for a particular application, contact the UK team at Da Vinci LS.

More information online

Latest News

Lab Asia 33.4 - August 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
Gas detection system protects Ghent University chemical technology laboratory
Explore more Arrow
Pollution Solutions Online
Leading UK biogas operator places first orders for new FlowSep technology
Explore more Arrow
Petro Online
Automated corrosion rating recognised in revised ASTM D665-25 standard
Explore more Arrow
Chromatography Today
Unlock high-resolution analysis of therapeutic oligonucleotides
Explore more Arrow